HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Correspondence: Submit a response Alert me when this article is cited Alert me when Correspondence are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Waters, C. H. Search for Related Content PubMed PubMed Citation Articles by Waters, C. H.

Managing the late complications of Parkinson's disease

From the Division of Movement Disorders, Department of Neurology, University of Southern California School of Medicine, Los Angeles, CA.

Address correspondence and reprint requests to Dr. Cheryl H. Waters, Department of Neurology, University of Southern California School of Medicine, 1510 San Pablo, #615, Los Angeles, CA 90033.

Abstract.

Most patients with Parkinson's disease (PD) receiving chronic levodopa therapy eventually manifest one or more motor response complications, including "wearing-off" phenomena and "on-off" phenomena. Additionally, as the disease progresses, motor, neurologic, and neuropsychiatric complications increase and may include freezing spells, falls, dementia, depression, and psychosis. The management of patients with advanced PD presents a special clinical challenge because patients may experience an enhanced sensitivity to small changes in plasma levodopa levels and because they may suffer adverse reactions to antiparkinsonian drugs. Management of advanced PD is directed toward decreasing the dose of the offending drug while raising the dose of an alternative drug, with the goal of maintaining symptom control. In this article, the spectrum of late complications experienced by patients with advanced PD and their management are discussed.

This article has been cited by other articles:

				C. H. Waters and J. J. Chen Pharmacologic Options for Treatment of Levodopa-Associated ``Wearing Off'' Journal of Pharmacy Practice, August 1, 2008; 21(4): 254 - 261. [Abstract] [PDF]

				J. W. Miller, J. Selhub, M. R. Nadeau, C. A. Thomas, R. G. Feldman, and P. A. Wolf Effect of L-dopa on plasma homocysteine in PD patients: Relationship to B-vitamin status Neurology, April 8, 2003; 60(7): 1125 - 1129. [Abstract] [Full Text] [PDF]